Tag Archives: HEA

PR Newswire

Clarivate Announces 2020 Revenue Cycle Awards Recipients

Leave a comment

Winners of the annual award include ThedaCare Regional Medical Center, University of Iowa Hospitals & Clinics and Essentia Health

LONDON, May 7, 2021 — Clarivate Plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today announced the 2020 winners of the annual Revenue Cycle Awards, issued by Healthcare Business Insights to US based companies since 2012. The Revenue Cycle Awards recognize healthcare organizations for achieving outstanding performance on revenue cycle KPIs, based on data from their most recent and preceding full fiscal years. The 2020 Revenue Cycle Awards recipients are: ThedaCare – WI, University of Iowa Hospitals & Clinics – IA and Essentia Health – MN.


The Revenue Cycle Awards were established in 2012 to recognize hospitals and health systems demonstrating strong performance on revenue cycle KPIs that indicate the fiscal health of an organization. While this year’s recipients faced challenges common to the entire healthcare community, at the onset of the pandemic, each participant adjusted operations to support staff and increased communication with patients to prevent the spread of COVID-19. For example, many expanded remote work for revenue cycle staff and developed workflows to meet increased demand for telehealth services. While adapting to these unforeseen challenges, leaders at these organizations were preparing for CMS price transparency regulations, which took effect in 2021, and managing ongoing improvement initiatives intended to further increase efficiency and accuracy in revenue cycle operations.

Winners were selected based on multiple KPIs, and the studied metrics were adjusted for the COVID-19 pandemic. In past years, metrics have been heavily focused on financial outcomes. For the 2020 Awards, that focus was lessened, and new metrics were included to assess the effectiveness of revenue cycle operations, such as the percentages of initial denials attributed to varying root cause categories, which provides insight into the efficiency and accuracy of staff workflows. Evaluation also included narratives provided by awards entrants describing recent revenue cycle initiatives, COVID-19 pandemic response, and more.

Beth Reed, Principal Analyst at Clarivate for Healthcare Business Insights solutions, said: "Innovation is at the heart of every successful growth strategy. Now, more than ever, hospitals and health systems must be flexible, able to adjust operations when needed to ensure the best care can be provided. It was important to acknowledge the effects of the COVID-19 pandemic in this year’s awards process. Each participant demonstrated their commitment to the health and safety of their staff and patients during a time of upheaval."

While all award recipients have high-performing revenue cycles in common, they represent varied segments of the healthcare landscape as defined by annual net revenue.

2020 Revenue Cycle Awards Winners:

$251 MILLION TO $1 BILLION NET REVENUE – ThedaCare

Based in Neenah, Wisconsin, ThedaCare includes seven hospitals and more than 30 clinics. The system includes five critical access hospitals and two general acute-care hospitals. ThedaCare features 460 beds and has generated approximately $734 million annual net revenue. The system operates under a partnership with Ensemble Health Partners, which provides full revenue cycle outsourcing.

Key achievements:

  • Top decile performance on first-pass appeal success rate in most recent fiscal year: 89.08%
  • Top decile year-over-year improvement on cost to collect: 29.40% decrease
  • Improved business office staff accuracy and efficiency, as well as payer relations, by integrating robotic process automation and AI into claim status workflows and account follow-up prioritization

$1 BILLION TO $2 BILLION NET REVENUE — University of Iowa Hospitals & Clinics

Based in Iowa City, Iowa, University of Iowa Hospitals & Clinics is an academic health system featuring an 860-bed hospital and more than 200 clinics. The system has generated approximately $1.9 billion net revenue.

Key achievements:

  • Top decile performance on percentage of dollars initially denied by payers due to insufficient clinical documentation in most recent fiscal year: 1.32%
  • Top decile performance on percentage of patients pre-registered before scheduled service in most recent fiscal year: 83.18%
  • Demonstrated leadership and community commitment by mitigating a local natural disaster’s effects on patient access to care during summer 2020, such as by identifying revenue cycle team members who could not work remotely due to power outages and developing safety protocols to prevent COVID-19 infection while they were brought back onsite temporarily

$2 BILLION+ NET REVENUE — Essentia Health

Based in Duluth, Minnesota, Essentia Health includes 14 hospitals, more than 70 clinics, several postacute and nonacute living facilities, and more, across Minnesota, Wisconsin, and North Dakota. The system features 1,150 beds and has generated approximately $2.0 billion net revenue.

Key achievements:

  • Top decile performance on percentage of patient payments made online in most recent fiscal year: 91.15%
  • Top decile year-over-year improvement on percentage of patients pre-registered before scheduled service: 90.67% improvement
  • Modified patient-facing revenue cycle processes to provide a positive in-person experience (such as through curbside registration) and virtual experience (such as through remote patient monitoring) during the pandemic

Clarivate and its Healthcare Business Insights solutions, is a proud partner to over 2,000 hospitals and health systems in the United States. We support healthcare leaders by optimizing performance, engaging and retaining employees, and providing insights to help navigate the evolving market – all while putting the patient first. As part of the Revenue Cycle Awards program, throughout 2021, Clarivate will highlight the work behind the numbers with exclusive content, connecting leaders from the winning organizations with the healthcare community. Submissions for the 2021 Revenue Cycle Awards will open later this year.

For more information, visit https://www.healthcarebusinessinsights.com/.

About Clarivate
Clarivate™ is a global leader in providing solutions to accelerate the lifecycle of innovation. Our bold mission is to help customers solve some of the world’s most complex problems by providing actionable information and insights that reduce the time from new ideas to life-changing inventions in the areas of science and intellectual property. We help customers discover, protect and commercialize their inventions using our trusted subscription and technology-based solutions coupled with deep domain expertise. For more information, please visit clarivate.com.

Media Contact
Catherine Daniel
media.enquiries@clarivate.com

Logo – https://techent.tv/wp-content/uploads/2021/05/clarivate-announces-2020-revenue-cycle-awards-recipients.jpg

Related Links :

Home

PR Newswire

Essence Group Launches New WeR@Home+ Smart Home Security Solution

Leave a comment

Leading Security Companies Begin Piloting New LTE-enabled Smart Home Solution in Europe

HERZLIYA, Israel, May 6, 2021 — Essence Group, a leading provider of IoT solutions for the global security and care markets, today announced the launch of WeR@Home+, a next generation security and home management platform. Essence is partnering with European security services providers, including Securitas Direct Switzerland, to pilot the new offering. 

Essence Group Launches New WeR@Home+ Smart Home Security Solution
Essence Group Launches New WeR@Home+ Smart Home Security Solution

WeR@Home+ leverages state-of-the-art IoT technology to expand Essence Group’s existing WeR@Home smart home management offering, including connectivity to LTE networks, a new family of connected security devices, and a rich set of reporting and analytics tools for service providers.

"WeR@Home+ represents our commitment to the mass deployment of smart living solutions that provide peace-of-mind to consumers, enabling them to simply and affordably manage their connected homes remotely, from anywhere and at any time," said Hagai Enoch, COO and head of Essence Group’s security division. "Providing a comprehensive smart home management system that is fully expandable and modular for any home environment, with self-installation and remote maintenance and configuration, we enable service providers across a range of industries – including telecommunications, insurance and real estate – to offer an array of value-added services to meet their customers’ specific needs while benefitting from increased ROI and more flexible business models."

WeR@Home+ boasts a range of new capabilities, including an updated central hub with multiple connectivity options. The new hub includes 4G LTE, in addition to Wi-Fi connectivity, and an extended battery backup to ensure the system is always connected. The high definition, battery-operated video camera is the first in the industry to provide HD video over secure radio frequency, connected locally to the hub. This offers highly secure enhanced video verification and unlimited video storage with an extended battery life of up to five years.

The highlight of the platform comprises the S5 Family of multi-functional detectors, featuring a magnetic door/window sensor, a motion sensor with multi-zone spherical lenses for enhanced coverage, a curtain sensor, and a multi-function button that can be programmed to perform a variety of security and smart home actions. Upgraded cloud capabilities provide unprecedented stability and flexibility for providers, including an interactive and fully customizable smartphone app and administration center, with enhanced reporting and analytics capabilities, enabling them to customize and deploy solutions tailored to customer needs.

"Securitas Direct Switzerland has enjoyed a long and fruitful relationship with Essence Group, our valued partner that has played an integral role in us becoming Switzerland’s leading security solutions provider," said Christian Chenaux, CEO Securitas Direct Switzerland. "We are very pleased to begin this pilot with the WeR@Home+ that provides innovation and the most flexible solution through which we can protect our customers from constantly evolving security threats by enabling them to seamlessly manage their home management and security protocols."

WeR@Home+ is an integral aspect of the realization of the Peace of Mind concept, recently introduced by Essence Group and intended to provide users with a better life experience and  close the gap between their limited resources and the increasing need for safety.

About Essence Group

Essence Group is a global technology leader with a mission to develop and deploy innovative, cloud-based, end-to-end security and healthcare solutions, underpinned by supporting services, that provide peace of mind to users. For over a quarter of a century, Essence has challenged convention by making care and safety both accessible and affordable. With over 70 million connected devices deployed worldwide, Essence helps people to live safer and more independent lives.

For more information: https://www.essence-grp.com/

Follow Essence Group on LinkedIn, Twitter and Facebook

Media Contact:

Finn Partners for Essence Group
Danny Sudwarts
Danny.sudwarts@finnpartners.com 
(+1) 469-297-2515

Photo: https://techent.tv/wp-content/uploads/2021/05/essence-group-launches-new-werhome-smart-home-security-solution.jpg

PR Newswire

FDA Grants Donisi De Novo Clearance for Innovative Contact-Free Multiparameter Health Sensing Solution

Leave a comment

TEL AVIV, Israel, May 5, 2021 — The U.S. Food and Drug Administration (FDA) has granted Donisi‘s revolutionary contact-free multiparameter measurement system de novo clearance, making Donisi the first to bring this innovative technology to the medical market.

Contact-Free Health Measurement and Decision Support. Donisi: Changing Lives Without Changing Lifestyles
Contact-Free Health Measurement and Decision Support. Donisi: Changing Lives Without Changing Lifestyles

In addition to the de novo clearance, the ingenuity of Donisi’s groundbreaking system was recently recognized via the publication of their clinical validation study in the Journal of Medical Engineering & Technology and winning first place in the MEDinISRAEL OpenMED Innovation Competition.

"I’m really proud of our team; we developed a medical device that can change the lives of millions of people. Our novel technology is now recognized and cleared by FDA which is a great accomplishment," said Donisi CEO, Yair Brosh.

Backed by 26 granted patents, the system applies a combination of proprietary optics, algorithms, and artificial intelligence to remotely detect and analyze surface-level micro-vibrations caused by the workings of internal organs such as heart and lungs.

Clinical results demonstrate Donisi’s technology maintains medical grade accuracy for people with different medical and physical conditions (physique, skin tone, etc.), without needing to remove clothing or connect the patient to wires or patches.

The company continues to develop its system, building ground-breaking solutions to measure and detect additional cardiopulmonary parameters, such as pulmonary congestion, in collaboration with the Cardiovascular Research Center at the Tel Aviv Sourasky Medical Center. Donisi has already undergone the FDA Presubmission process for the identification of atrial fibrillation (AFib) and plans for additional submissions.

"Having been with the company since its first year, I am awed and inspired to be part of the team that is bringing this amazing futuristic technology to life," said Donisi Chief Medical Officer Dr. Sagi Polani. "This is an exciting step in our path to fulfilling our mission of changing lives without changing lifestyles. As we move forward, I can envision how our medical device will bridge the continuum of care from hospital to home, impacting lives and health," he continued.

"Chartered Group’s investment in Donisi Health indicates our belief in its development of the innovative optical sensing system that would contribute to resolve various challenges in the healthcare market including the silver tsunami and shift from hospital care to home care," said Eyal Agmoni, Chairman of Chartered Group Technology Division, Donisi’s lead investor, and Managing General Partner of Japan Israel High Tech Ventures 2. "The medical market’s response to this development has been extremely enthusiastic and we are excited with the progress made by such a dedicated team of experts."

For more information or to request an interview, please reach out to Donisi Health. 

 

 

PR Newswire

Cleveland Clinic, Lifebanc and Transplant Connect Develop Automated Donor Referral Process

Leave a comment

New system streamlines organ donation process, helping to save, heal more lives through donation, transplantation

CLEVELAND, May 4, 2021 — Cleveland Clinic, Lifebanc and Transplant Connect have designed and launched a fully automated donor referral system to streamline the process for hospital staff identifying and evaluating potential organ, tissue and eye donors.


The new process was launched successfully throughout the Cleveland Clinic health system in northeast Ohio in February 2021, following a successful pilot at Cleveland Clinic main campus and Cleveland Clinic Fairview Hospital in 2020. To implement a donor referral process that would work with each of the organization’s platforms, Cleveland Clinic collaborated with Lifebanc, the non-profit organ procurement organization (OPO) for northeast Ohio, and Transplant Connect, a medical software company specializing in donation-transplant software.

One person’s donation can save the lives of up to eight people and enhance the lives of 50 more. The Centers for Medicare & Medicaid Services mandates that every U.S. hospital refer all deaths and imminent deaths to its designated OPO in a timely manner.  When using the existing manual process, which is labor-intensive and time-consuming, hospital staff must identify each potential donor, place a call to notify the OPO and communicate relevant information to allow the donation evaluation to proceed.

"Our clinical and technical caregivers at Cleveland Clinic are continuously working to make improvements to identify candidates for organ donation," said Brent Hicks, senior director of digital and clinical health at Cleveland Clinic. "This resulted in significant workflow and time-saving improvements but still required a lengthy phone call to the OPO. With the new process, a phone call is no longer required. The entire donor referral process is now automated and in use in all of our northeast Ohio locations."

A Cleveland Clinic team of nurses, end-of-life care professionals, and technology experts worked together to automate the internal process while maintaining quality, privacy, and patient safety. The project came to fruition with support from a Cleveland Clinic Caregiver Catalyst Grant that rewards with funds the innovation and initiative of Cleveland Clinic caregivers.

"We pride ourselves on providing high-quality, safe care, and keep looking for ways to innovate," said Meredith Foxx, executive chief nursing officer at Cleveland Clinic. "Working closely with Lifebanc and Transplant Connect, we made improvements to our organ-donation process to benefit patient care, which translates into our nurses spending more time at the bedside with the patient and their family." 

Transplant Connect’s electronic medical record software, known as iTransplant, is used by Lifebanc and most other OPOs in the United States. It facilitates nearly 75% of U.S. organ transplants from deceased donation.  Its automated donor referral interface, known as iReferral, is currently in nationwide rollout with many hospitals and OPOs.  The iReferral interface allows for donor referrals to be sent automatically, immediately and securely from the hospital’s electronic medical records system to the OPO’s iTransplant system.

"This iReferral launch with Cleveland Clinic and Lifebanc is the largest deployment of automated donor referral technology to date," said John Piano, founder and chief executive officer at Transplant Connect and inventor of the automated donor referral.

"We are honored to have worked through this process with Transplant Connect and Cleveland Clinic," said Lifebanc’s Chief Executive Officer Gordon Bowen. "By streamlining the organ donation referral process, the results will lead to more donors and more organs for those waiting for a life-saving gift."

ABOUT CLEVELAND CLINIC: Cleveland Clinic – now in its centennial year – is a nonprofit multispecialty academic medical center that integrates clinical and hospital care with research and education. Located in Cleveland, Ohio, it was founded in 1921 by four renowned physicians with a vision of providing outstanding patient care based upon the principles of cooperation, compassion and innovation. Cleveland Clinic has pioneered many medical breakthroughs, including coronary artery bypass surgery and the first face transplant in the United States. U.S. News & World Report consistently names Cleveland Clinic as one of the nation’s best hospitals in its annual "America’s Best Hospitals" survey. Among Cleveland Clinic’s 70,800 employees worldwide are more than 4,660 salaried physicians and researchers, and 18,500 registered nurses and advanced practice providers, representing 140 medical specialties and subspecialties. Cleveland Clinic is a 6,500-bed health system that includes a 173-acre main campus near downtown Cleveland, 19 hospitals, more than 220 outpatient facilities, and locations in southeast Florida; Las Vegas, Nevada; Toronto, Canada; Abu Dhabi, UAE; and London, England. In 2020, there were 8.7 million total outpatient visits, 273,000 hospital admissions and observations, and 217,000 surgical cases throughout Cleveland Clinic’s health system. Patients came for treatment from every state and 185 countries. Visit us at clevelandclinic.org. Follow us at twitter.com/ClevelandClinic. News and resources available at newsroom.clevelandclinic.org.

ABOUT LIFEBANC: Lifebanc is Northeast Ohio’s non-profit organ, eye and tissue recovery organization with a mission to save and heal lives. The organization serves over 4 million people and works with 80 hospitals in a 20-county area. Lifebanc facilitates the organ, eye and tissue recovery and donation processes, provides extensive care and support services to donor families, as well as coordinates community outreach and education programs to encourage registration on the Ohio Donor Registry. For more information on Lifebanc or to register as an organ, eye and tissue donor visit www.lifebanc.org

ABOUT TRANSPLANT CONNECT:  Transplant Connect is a socially-conscious medical software enterprise based in Los Angeles. Its iTransplant Donation-Transplant Ecosystem Software Platform is used to facilitate nearly 75% of all deceased donation in the U.S. as well as across a number of other countries and is relied upon every day by many thousands of medical professionals at hospitals, OPOs, transplant centers, tissue banks, eye banks, transport companies and other organizations.  Integrated with its interoperable iTransplant Platform, the company’s iReferral Hospital EMR Interface technology is in wide U.S. rollout and is disrupting and replacing the inefficient and time-consuming manual donor referral process between hospitals and OPOs.  www.transplantconnect.com

ABOUT ORGAN, TISSUE AND EYE DONATION:  Despite the increase in organ, eye and tissue donors there remains a critical organ shortage in the United States. There are currently 118,195 people waiting for a life-saving organ transplant across the country. There are 1,655 people waiting in Northeast Ohio alone. In 2020, 360 people in Northeast Ohio either died waiting for an organ or became too sick to transplant.

The best chance those still waiting have at receiving the life-saving transplant they need is by increasing the number of people who register their wishes to be an organ, eye and tissue donor. In 2020, over 47,712 people in Northeast Ohio registered for the first time on the Ohio Donor Registry.

To learn more about what it means to be an organ, eye and tissue donor and to register online, please click here.  https://www.lifebanc.org/how-to-help/register-as-a-donor/

 

Related Links :

http://www.transplantconnect.com

PR Newswire

Ascensia Rolls Out The On@Pro Online Educational Platform for Healthcare Professionals in Collaboration With the Tumaini Institute

Leave a comment

BASEL, Switzerland, April 28, 2021 — Ascensia Diabetes Care, a leading global diabetes care company, has announced today that it has rolled out an online educational platform for continuous personal learning aimed at healthcare professionals working with people with diabetes. The On@Pro tool, which was originally piloted in September 2020, has been developed in partnership with the TUMAINI Institute in Germany, through a collaboration with Professor Peter Schwarz, a globally renowned diabetes expert.

Ascensia Diabetes Care has rolled out an online educational platform for continuous personal learning aimed at healthcare professionals working with people with diabetes
Ascensia Diabetes Care has rolled out an online educational platform for continuous personal learning aimed at healthcare professionals working with people with diabetes

On@Pro is currently available in 13 countries, including the Middle East (Saudi Arabia, Bahrain, Kuwait, Lebanon and the UAE), South Africa, Egypt, India, Malaysia, Singapore, China Hong Kong, the Philippines and Nepal, and there are plans to add additional markets over the course of 2021. It can be accessed via Android, Microsoft and iOS enabled devices such as smartphones, tablets and PCs, through a personal access code which can be obtained from Ascensia in countries where the tool is currently being offered. Access is free of charge to ensure access for as many healthcare professionals as possible.

The platform currently offers a total of 32 modules[1], all in English language, relating to various aspects of diabetes care and management. Each module includes a 3-4 minute introductory video, a set of educational slides and an assessment tool that enables the user to receive certification[2]. In certain markets, including South Africa, Saudi Arabia, Lebanon and UAE, the tool has been accredited and completion of modules can lead to CME (Continuing Medical Education) credits.

Rob Schumm, President at Ascensia Diabetes Care commented: "Through our conversations with healthcare professionals, we became aware of a strong desire for a more comprehensive education platform in diabetes. As part of our ongoing commitment to the diabetes community, one of our priorities is to provide free educational resources to healthcare professionals that can build a greater understanding of diabetes and its management. We believe this will equip HCPs, including GPs, nurses and pharmacists, with the knowledge needed to advise and support people to more effectively self-manage their condition. The On@Pro platform is easily accessible and offers bite-size modules for effective and efficient continuous learning. Alongside On@Pro, we have developed other educational initiatives such as the EMEA Nurse Symposium and virtual courses for pharmacists and other healthcare stakeholders in North America. We believe that widespread education can empower healthcare professionals to help improve and simplify the lives of people living with diabetes."

"We wanted to provide an attractive and unique educational portal covering the different aspects of diabetes care relevant to healthcare professionals via a state-of-the-art platform. This tool enables personal continuous medical education that results in a CME certificate for the successful completion of the education program," concluded Prof. Dr. med. habil. Peter Schwarz, at the TUMAINI Institute. 

The modules are split into basic, advanced and add-on modules, and each one takes approximately 30 minutes to complete. The 18 basic modules cover topics relating to diabetes prevention, diabetes-related complications, diabetes in daily living and diabetes management, including nutrition and activity, self-monitoring of blood glucose, oral antidiabetic drugs, and insulin dosing. The nine advanced modules cover specific types of diabetes sub-groups or diabetes in specific scenarios – in pregnancy, in the elderly population, or in adolescents and children. They also look at accuracy in specific situations, such as low blood glucose ranges, gestational diabetes and among CGM and FGM users. Finally the four add-on modules cover e-health in diabetes, diabetes in Ramadan and blood glucose awareness training.

1. The content of the modules has been prepared by Prof. Peter Schwarz and the TUMAINI Institute and reflects their respective personal scientific views. Ascensia has no influence over the content of specific modules.
2. Certification granted by the University of Dresden and TUMAINI Institute, Germany.

 

Related Links :

https://www.ascensia.com

PR Newswire

Jolly Good and Teijin Pharma Form a Partnership to Develop VR Digital Therapeutics for Depression

Leave a comment

TOKYO, April 23, 2021 — Jolly Good Inc. ("Jolly Good") and Teijin Pharma Ltd. ("Teijin Pharma") have signed a business partnership agreement to develop VR digital therapeutics ("VR DTx") for Major Depressive Disorder (MDD). Together, they will promote the development of VR DTx for depression, aiming for PMDA regulatory approval.  

Jolly Good and Teijin Pharma Form a Partnership to Develop VR Digital Therapeutics for Depression
Jolly Good and Teijin Pharma Form a Partnership to Develop VR Digital Therapeutics for Depression

Background of this agreement

This all started when Jolly Good won "Home Healthcare Award" in a program held by Teijin in Dec., 2020. Focusing of Jolly Good’s development of Cognitive Behavioral Therapy VR ("CBT VR") for psychiatric disorders, this partnership will leverage Jolly Good’s VR technology and Teijin Pharma’s expertise in knowledge and strategic skills. They have agreed that they can support healthcare workers as well as improving the quality of life of patients.

From now on, Jolly Good and Teijin Pharma will continue to develop the system and perform clinical trials to register for PMDA regulatory approval.

About Cognitive Behavioral Therapy

Cognitive Behavioral Therapy ("CBT") is a psychotherapy supporting patients to change their thoughts and behaviors by talking to a therapist. This therapy is based on the theory that your cognition on how you perceive things affects your mental and behavior pattern. CBT has been used as one of the options for non-medical treatment. 

Our developing CBT VR for depression will be used as a supplement to the actual face-to-face therapy, supporting parts such as emotional behavior or bias of perspective. Not only will it improve the effectiveness of the treatment, but it will also lessen the burden of both healthcare workers and patients.

What is a DTx division (https://vrdtx.com/en)

Jolly Good established "DTx division" in April this year, consisting of psychiatrist, regulatory specialists, and business producers familiar with VR training for people with developmental disorders. This division will focus on developing the fundamental system of digital therapeutics using VR.

DTx division will expand their pipeline to other psychiatric diseases and lifestyle diseases using the fundamental system of VR DTx. 

About Jolly Good Inc. (https://jollygood.co.jp/)

Jolly Good is a medical technology company that develops high-precision VR solutions and AI-based medical and welfare services that analyze user behavior in the VR space. Using technologies such as VR and AI, the company is accelerating human growth and social rehabilitation in medical education, support for persons with disabilities, treatment of mental illness, and so on, as well as developing services to support the evolution of medical care and finding purposes in life, in collaboration with various research institutions and companies.

About the Teijin Group

Teijin (TSE: 3401) is a technology-driven global group offering advanced solutions in the fields of environmental value; safety, security and disaster mitigation; and demographic change and increased health consciousness. Originally established as Japan’s first rayon manufacturer in 1918, Teijin has evolved into a unique enterprise encompassing three core business domains: high-performance materials including aramid, carbon fibers and composites, and also resin and plastic processing, films, polyester fibers and products converting; healthcare including pharmaceuticals and home healthcare equipment for bone/joint, respiratory and cardiovascular/metabolic diseases, nursing care and pre-symptomatic healthcare; and IT including B2B solutions for medical, corporate and public systems as well as packaged software and B2C online services for digital entertainment. Deeply committed to its stakeholders, as expressed in the brand statement "Human Chemistry, Human Solutions," Teijin aims to be a company that supports the society of the future. The group comprises more than 170 companies and employs some 20,000 people across 20 countries worldwide. Teijin posted consolidated sales of JPY 853.7 billion (USD 8.0 billion) and total assets of JPY 1,004.2 billion (USD 9.4 billion) in the fiscal year that ended on March 31, 2020.

Please visit www.teijin.com

PR Newswire

US State Turns on COVID-19 Vaccine Appointment Scheduling Hotline in Less Than a Day with Bright Pattern

Leave a comment

COVID-19 vaccine appointment hotline deployed in record time – 23 hours – by Atento and Bright Pattern with an agreement for 1500 agents

SOUTH SAN FRANCISCO, Calif., April 1, 2021 — Bright Pattern, a leading provider of AI-powered cloud contact center software, has been deployed to help schedule COVID-19 vaccination appointments. The appointment scheduling hotline needed to be deployed in less than a day to accommodate the rapid distribution of vaccinations to the citizens of the state. Bright Pattern, the contact center software with the fastest deployment time of less than half the industry average, was deployed in 23 hours, making it the fastest COVID hotline deployed to help decrease the spread of COVID-19. In just 23 hours, 200 remote agents were trained and started handling calls on the Bright Pattern platform with a record 14,000 calls on day one of the campaign.

Atento, one of the top five customer relationship management and business process outsourcing providers (BPO), evaluated many contact center solutions including Genesys and Avaya, but partnered with Bright Pattern because of its remote agent capabilities, ease of use, and speed of deployment. "Bright Pattern had a contact center up and running in just 23 hours. The other vendors we were talking with simply couldn’t deploy the agents quickly enough for this urgent need," said Hugo Martinez, Regional Technical Account Manager and Security at Atento. The Bright Pattern platform also provided the scalability needed. "In just a week of using Bright Pattern, we saw a 70% increase in agents and have plans to grow to 1500 agents over the next month," continued Martinez.

Bright Pattern has helped numerous existing and new customers deploy remote teams, provide safe work environments for agents, and improve customer satisfaction amid a global pandemic. Some of the innovative use cases Bright Pattern has seen since the pandemic include:

  • The 2nd largest US bank deployed Bright Pattern in 10 days for over 2,000 remote agents handling over 3 million interactions per month to support COVID-19 paycheck protection program – Read More
  • The South Korea Center for Disease Control is revolutionizing their contact tracing program with innovative cloud contact center technology to contain the spread of COVID-19 – Read More
  • The UK National Health Service (NHS) launched a technology-reliant testing and tracing campaign to combat the spread of COVID-19, utilizing Bright Pattern Contact Center Software for omnichannel communications – Read More
  • Bright Pattern helps Naver, often referred to as "the Google" of South Korea and creator of the LINE messaging app go remote amid COVID-19 – Read More
  • A leading European travel exploration company moved all call center agents remote during COVID-19 thanks to Bright Pattern cloud-based contact center software – Read More
  • Cenaced, a non-profit healthcare organization, is using Bright Pattern to deploy remote agents and offer free telehealth services to help citizens in Mexico dealing with stress during the quarantine – Read More
  • A multi-state retail chain triages over 50% of pandemic call volume using Bright Pattern AI for bots and conversational IVR – Read More
  • A leading brick-and-mortar luxury retailer in Europe moved fully remote and online. They also used the WhatsApp messaging platform so that in-store personnel could be redeployed to capture and share videos of requested products with customers chatting online, providing personal concierge service via digital channels like chat and messengers.

"COVID has spurred companies to think differently about how they communicate with their customers, and companies have become more nimble and innovative as a result. Getting vaccines out has been an issue, and Atento and Bright Pattern teamed up to deploy the fastest vaccine scheduling hotline yet using nimble cloud technology for remote agents in less than a day," said Ted Hunting, SVP of Marketing at Bright Pattern.

Companies of all sizes select Bright Pattern to support their customer care organizations because of its simplified – yet robust – omnichannel platform, offering traditional channels; emerging channels like Facebook Messenger; in-app customer support; enterprise functionality; cloud-first architecture; and the ability to modify without the time and cost of professional services. Bright Pattern was recently recognized by Ovum as a Market Challenger, by Omdia for best platform functionality, by Frost & Sullivan as a top-performing vendor, and by Gartner as a leader in the Call Center FrontRunners Quadrant.

About Bright Pattern
Bright Pattern provides the simplest and most powerful AI-powered omnichannel contact center software for innovative midsize and enterprise companies. To make customer service brighter, easier, and faster than ever before, Bright Pattern offers the only true omnichannel cloud platform with embedded AI that can be deployed quickly and nimbly by business users—without costly professional services. Bright Pattern allows companies to offer an effortless and personal customer experience across channels like voice, text, chat, email, video, messengers, and bots. Bright Pattern also allows companies to measure and act on every interaction on every channel with embedded AI omnichannel quality management. The company was founded by a team of industry veterans who pioneered the leading contact center solutions and are now delivering an architecture for the future with an advanced cloud-first approach. Bright Pattern’s cloud contact center solution is used globally in over 26 countries and 12 languages.

About Atento
Atento is one of the five largest global providers for client relationship management and business process outsourcing services nearshoring for companies that carry out their activities in the United States. Since 1999, the company has developed its business model in 13 countries with a workforce of 150,000 employees. Atento has over 400 clients for which it provides a wide range of CRM/BPO services through multiple channels. Its clients are leading multinational companies in the technology, digital, telecommunications, finance, health, consumer and public administration sectors, amongst others. Atento trades under ATTO on the New York Stock Exchange. In 2019 Atento was recognized by Great Place to Work® as one of the 25 World’s Best Multinational Workplaces and as one of the Best Places to Work in Latin America. For more information: www.atento.com

Related Links :

http://www.brightpattern.com

PR Newswire

SafeRide unveils support for Vehicle Health Management industry standard at the ATA-TMC spring conference

Leave a comment

SafeRide’s vInsight™ platform supports the SAE JA6268 standard and enables state-of-the-art Integrated Vehicle Health Management (IVHM) solutions for fleets, OEMs, and suppliers

TEL AVIV, Israel, April 1, 2021 — SafeRide Technologies, a leading provider of AI-based vehicle health management (VHM) solutions unveiled today that its vInsight™ platform has been extended to support the SAE JA6268 VHM standard. The vInsight VHM platform includes a deep learning development tool for fleets, OEMs, and Tier-1 suppliers that generates VHM monitors for deployment on board the vehicle or in the cloud.

The SAE Health-Ready Components and Systems (HRCS) Consortium™, a subgroup of SAE, was created to increase the impact of SAE’s JA6268 standard. It provides standard templates for common vehicle components and systems that describe their failure modes, the mechanisms to monitor their health, and the data required to enable their health monitoring.

SafeRide is collaborating with HRCS members, including General Motors, Volvo Group, Garret in Motion, Nexteer, and others, to implement the best practices and guidance provided in the SAE JA6268 standard to facilitate the integration of IVHM functionality in health-ready components and systems to meet the needs and objectives of the industry in a cost-effective manner.

SafeRide together with other HRCS partners demonstrated at the American Trucking Association’s Technology and Maintenance Council (ATA-TMC) conference on March 31st the benefits of using the JA6268 standard to streamline the delivery of vehicle health data to fleet operators and OEMs.

At the ATA-TMC conference SafeRide presented how JA6268 templates can be imported into and customized by the vInsight Developer tool to enable automated, simplified, and efficient development and delivery of vehicle health indicators to fleets, OEMs, and suppliers.

Existing VHM solutions rely on diagnostic trouble codes (DTCs) and telematics data to detect and predict malfunctions. DTCs can only detect failures after they occur, and they provide limited insights about the problem. This can lead to a complex and expensive repair process, and sometimes a wrong diagnosis. Current telematics solutions are limited by network bandwidth and access to data; therefore, they may fail to address the growing complexity of modern vehicles.

"OEMs and fleets are paying billions of dollars every year in warranty claims and maintenance cost" said Gil Reiter, SafeRide’s Vice President of Product Management and Marketing. "The vInsight platform, with JA6268 support, can help OEMs and fleets reduce these costs significantly, while enabling smooth and interoperable deployment into existing fleets and new vehicles."

SafeRide’s vInsight™ platform enables customers to develop, train, optimize, test, and deploy deep-learning based algorithms for VHM using a rich library of production grade models and design templates for major vehicle systems such as engine, transmission, emission, braking, battery management, and more. vInsight Developer can generate compressed and optimized models for embedded deployment onboard vehicles, or for remote deployment in the cloud.

"SafeRide’s vInsight platform brings together AI and domain knowledge" said Steve Holland, SAE HRCS Consortium Chairman and former GM VHM Chief Technologist. "This unique combination enables powerful IVHM solutions that are changing how we manage vehicle health".

SafeRide’s vInsight solution is currently deployed in pilot projects with several major OEMs and fleets.

For more information about vInsight visit www.saferide.io/vinsight, or to request a demo of the vInsight VHM platform email info@saferide.io.

About SafeRide Technologies 

SafeRide Technologies is a leading provider of AI-based vehicle health management, data analytics, and cybersecurity solutions that provide timely vehicle insights to automakers and fleet owners and help them reduce warranty costs, limit recalls, minimize vehicle downtime, lower total cost of ownership, optimize vehicle performance, and prevent reputation loss. For more information, visit www.saferide.io. 

Logo – https://mma.prnasia.com/media2/1212705/SafeRide_Technologies_Logo.jpg?p=medium600  

Related Links :

https://saferide.io/

PR Newswire

AI and Cloud to Empower the European Telehealth Market Securing Efficient Access to Essential Healthcare Services

Leave a comment

By 2026, the European telehealth market is estimated to witness more than a four-and-a-half-fold growth, garnering $20.7 billion revenue, finds Frost & Sullivan

SANTA CLARA, Calif., March 17, 2021 — Frost & Sullivan’s recent analysis, Innovative Business Models Powering the Telehealth Market in Europe, finds that the severe impact of COVID-19 on the healthcare sector across Europe catapulted the use of telehealth. It ensured efficient access to essential healthcare services for patients with chronic conditions or those requiring acute and urgent care during the pandemic. The healthcare sector shift to the "anytime and anywhere" model in response to the pandemic resulted in a massive surge in the region’s telehealth market. By 2026, the booming market is estimated to witness more than a four-and-a-half-fold growth, garnering $20.7 billion revenue from $4.41 billion in 2019, up at a strong compound annual growth rate (CAGR) of 29.4%.

 

AI and Cloud to Empower the European Telehealth Market Securing Efficient Access to Essential Healthcare Services
AI and Cloud to Empower the European Telehealth Market Securing Efficient Access to Essential Healthcare Services

For further information on this analysis, please visit: http://frost.ly/5gh

"Rising demand for consumer-centric services and tools in Europe’s healthcare system is leading to the development of new business models," said Chandni Mathur, Healthcare & Life Sciences Senior Industry Analyst at Frost & Sullivan. "Adoption of advanced technologies such as artificial intelligence (AI), virtual reality, blockchain, the internet of medical things (IoMT), wearables, and cloud computing is expected to disrupt the telehealth market. 5G will feature as a key enabler to boost the adoption and effective utilization of these disruptive technologies."

Mathur added: "From a product type perspective, virtual visits will lead the overall telehealth market, registering growth at an astounding CAGR of 41.2% over the forecast period, followed by remote patient monitoring (RPM) at 20.4%. Further, mhealth and personal emergency response systems (PERS) will also contribute significantly to the market, garnering revenue at 27.5% and 7.7% CAGR, respectively."

Telehealth equipment makers, service providers, and technology enablers have an uphill task catering to the pandemic-driven sudden demand, which will require business model revision across the telehealth ecosystem. As a result, telehealth market participants have the following growth opportunities:

  • Behavioral health: Partner with focused solutions providers and pharma companies to offer digital therapeutic solutions. 
  • RPM for real-world evidence collection: Standardize data collected through RPM devices and mobile apps that record patient-reported outcomes.
  • Doctor-to-doctor communication: Doctor-patient communication, information exchange, and integration with electronic medical records (EMRs) are expected to be game-changers.
  • Consumer wearables: Cater to the entire care continuum needs, track basic vital parameters and integrate with health records. The use of consumer wearables has risen, especially as patients become more aware of and involved in their health and wellness journey.

Innovative Business Models Powering the Telehealth Market in Europe is the latest addition to Frost & Sullivan’s Healthcare & Life Sciences research and analyses available through the Frost & Sullivan Leadership Council, which helps organizations identify a continuous flow of growth opportunities to succeed in an unpredictable future.

About Frost & Sullivan

For six decades, Frost & Sullivan has been world-renowned for its role in helping investors, corporate leaders and governments navigate economic changes and identify disruptive technologies, Mega Trends, new business models and companies to action, resulting in a continuous flow of growth opportunities to drive future success. Contact us: Start the discussion.

Innovative Business Models Powering the Telehealth Market in Europe

MFBD

Contact:
Mariana Fernandez
Corporate Communications
E: Mariana.Fernandez@frost.com
http://ww2.frost.com

Related Links :

http://www.frost.com

PR Newswire

Medeze Commended by Frost & Sullivan for Dominating the Stem Cell Banking Market with Its Pioneering, Full Spectrum Services

Leave a comment

Medeze’s expansion strategies and customer-focused innovation in MSC banks and regenerative therapies have enabled it to garner a major share of the market

SINGAPORE, March 12, 2021 — Based on its recent analysis of the Southeast Asia stem cell banking market, Frost & Sullivan recognizes Medeze Group with the 2020 Southeast Asia Stem Cell Banking Technology Innovation Leadership Award and the 2020 Thai Stem Cell Banking Company of the Year Award. Medeze has launched numerous first-to-market solutions in the Southeast Asian market and has maintained its leadership position in the Thai market with more than a 60% market share.

The company provides storage services for 60 years, instead of the standard 20 or 25 years. With ten regional branches in Thailand, Singapore, Vietnam, Myanmar, Indonesia, South Korea, Taiwan, Cambodia, New Zealand, and Australia, Medeze is firmly entrenched in the market.
The company provides storage services for 60 years, instead of the standard 20 or 25 years. With ten regional branches in Thailand, Singapore, Vietnam, Myanmar, Indonesia, South Korea, Taiwan, Cambodia, New Zealand, and Australia, Medeze is firmly entrenched in the market.

"Medeze was the first stem cell banking company in Thailand to bank mesenchymal stem cells (MSC) derived from placenta, cord tissue, and adipose tissue. Its excellence in conducting advanced stem cell-based regenerative therapies is reflected in more than 15,000 successful treatments in applications that help address emerging healthcare needs," said Norazah Bachok, Analyst, Best Practice, Asia-Pacific. "Through its non-invasive prenatal test (NIPT) application, it managed to capture a 70% market share in Thailand within a year of introduction. Its comprehensive and advanced technologies, prestigious global accreditations, and strong customer-centric relationships contributed to a tremendous impact on its customer satisfaction rate, which is greater than 90%."

On top of being Thailand’s largest and most experienced MSC bank, Medeze offers cord blood banking, cord tissue banking, and adipose tissue banking. In addition, the company is involved in the full spectrum of stem cell research, with its research and development (R&D) department focused on assisting researchers and scientists in evolving the field of advanced regenerative medicine that could become a crucial tool in saving lives. The company has shown a firm commitment to upholding industry-leading quality and international standards, customer satisfaction, and future-focused initiatives both in storage and in the development of clinical applications and research.

In addition to innovative stem cell applications, Medeze has experienced success in stem cell therapy for osteoarthritis, rheumatoid arthritis, cirrhosis, and other degenerative diseases and has successfully delivered quality services with more than 97% customer satisfaction. Moreover, the company has provided storage services for 60 years, instead of the standard 20 or 25 years. With ten regional branches in Thailand, Singapore, Vietnam, Myanmar, Indonesia, South Korea, Taiwan, Cambodia, New Zealand, and Australia, Medeze is firmly entrenched in the market.

"Medeze pioneered the application of cord MSCs, early amniotic fluid collection, and the NIPT application to emerge as the undisputed leader in the market," noted Bachok. "Aggressive development of advanced facilities, excellent technology innovations, and continuous research partnerships with leading global industry organizations have established it as the stem cell banking partner of choice."

Each year, Frost & Sullivan presents a Technology Innovation Leadership Award to the company that has demonstrated uniqueness in developing and leveraging new technologies that deliver significant customer value.

Frost & Sullivan presents a Company of the Year Award to the organization that demonstrates excellence in terms of growth strategy and implementation in its field. The award recognizes a high degree of innovation with products and technologies and the resulting leadership in terms of customer value and market penetration.

Frost & Sullivan Best Practices Awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analyses, and extensive secondary research to identify best practices in the industry.

About Frost & Sullivan

For six decades, Frost & Sullivan has been world-renowned for its role in helping investors, corporate leaders, and governments navigate economic changes and identify disruptive technologies, Mega Trends, new business models, and companies to action, resulting in a continuous flow of growth opportunities to drive future success. Contact us: Start the discussion. Contact us: Start the discussion.

Contact:
Kala Mani.S.
P: +6012-2323 550
E: Kala.Manis@frost.com

About Medeze Group

We are creating a standard of practice that is paving the way for a transformation in the way we look at age and illness. We look towards a day when saving newborn stem cells will be a routine practice and stem cell therapy will be the first line of treatment for many of today’s incurable diseases. Contact us for more info.

Photo – https://techent.tv/wp-content/uploads/2021/03/medeze-commended-by-frost-sullivan-for-dominating-the-stem-cell-banking-market-with-its-pioneering-full-spectrum-services.jpg

 

Related Links :

Frost New Home page v2